CLOSINGS: View Closings

Medical milestone: US OKs marijuana-based drug for seizures

U.S. health regulators on Monday approved the first prescription drug made from marijuana, a milestone that could spur more research into a drug that remains illegal under federal law, despite growing legalization for recreational and medical use.

Posted: Jun 25, 2018 3:47 PM

WASHINGTON (AP) — U.S. health regulators on Monday approved the first prescription drug made from marijuana, a milestone that could spur more research into a drug that remains illegal under federal law, despite growing legalization for recreational and medical use.

The Food and Drug Administration approved the medication, called Epidiolex, to treat two rare forms of epilepsy that begin in childhood. But it’s not quite medical marijuana.

The strawberry-flavored syrup is a purified form of a chemical ingredient found in the cannabis plant — but not the one that gets users high. It’s not yet clear why the ingredient, called cannabidiol, or CBD, reduces seizures in some people with epilepsy.

British drugmaker GW Pharmaceuticals studied the drug in more than 500 children and adults with hard-to-treat seizures, overcoming numerous legal hurdles that have long stymied research into cannabis.

FDA officials said the drug reduced seizures when combined with older epilepsy drugs.

The FDA has previously approved synthetic versions of another cannabis ingredient for medical use, including severe weight loss in patients with HIV.

Epidiolex is essentially a pharmaceutical-grade version CBD oil, which some parents already use to treat children with epilepsy. CBD is one of more than 100 chemicals found in marijuana. But it doesn’t contain THC, the ingredient that gives marijuana its mind-altering effect.

Physicians say it’s important to have a consistent, government-regulated version.

“I’m really happy we have a product that will be much cleaner and one that I know what it is,” said Dr. Ellaine Wirrell, director of the Mayo Clinic’s program for childhood epilepsy. “In the artisanal products there’s often a huge variation in doses from bottle to bottle depending on where you get it.”

Side effects with the drug include diarrhea, vomiting, fatigue and sleep problems.

Several years ago, Allison Hendershot considered relocating her family to Colorado, one of the first states to legalize marijuana and home to a large network of CBD producers and providers. Her 13-year-old daughter, Molly, has suffered from severe seizures since she was 4 months old. But then Hendershot learned about a trial of Epidiolex at New York University.

“I preferred this to some of those other options because it’s is a commercial product that has gone through rigorous testing,” said Hendershot, who lives in Rochester, New York.

Since receiving Epidiolex, Hendershot says her daughter has been able to concentrate more and has had fewer “drop” seizures — in which her entire body goes limp and collapses.

CBD oil is currently sold online and in specialty shops across the U.S., though its legal status remains murky. Most producers say their oil is made from hemp, a plant in the cannabis family that contains little THC and can be legally farmed in a number of states for clothing, food and other uses.

The immediate impact of Monday’s approval on these products is unclear.

FDA Commissioner Scott Gottlieb suggested the agency would be scrutinizing CBD products with “uncertain dosages and formulations.”

“We are prepared to take action when we see the illegal marketing of CBD-containing products with serious, unproven medical claims,” Gottlieb said in a statement.

The FDA previously issued warnings to CBD producers that claimed their products could treat specific diseases, such as cancer or Alzheimer’s. Only products that have received formal FDA approval can make such claims, typically requiring clinical trials costing millions.

Most CBD producers sidestep the issue by making only broad claims about general health and well-being.

Industry supporters downplayed the impact of the FDA approval.

“I don’t know a mom or dad in their right mind who is going to change what’s already working,” said Heather Jackson, CEO of Realm of Caring, a charitable group affiliated with Colorado-based CW Hemp, one of nation’s largest CBD companies. “I really don’t think it’s going to affect us much.”

Jackson’s group estimates the typical family using CBD to treat childhood epilepsy spends about $1,800 per year on the substance.

A GW Pharmaceuticals spokeswoman said the company would not immediately announce a price for the drug, which it expects to launch in the fall. Wall Street analysts have previously predicted it could cost $25,000 per year, with annual sales eventually reaching $1 billion.

For their part, GW Pharmaceuticals executives say they are not trying to disrupt products already on the market. The company has pushed legislation in several states to make sure its drug can be legally sold and prescribed.

The FDA approval for Epidiolex is technically limited to patients with Dravet and Lennox-Gastaut syndromes, two rare forms of epilepsy for which there are few treatments. But doctors will have the option to prescribe it for other uses.

The new medication enters an increasingly complicated legal environment for marijuana.

Nine states and the District of Columbia have legalized marijuana for recreational use. Another 20 states allow medical marijuana, but the U.S. government continues to classify it as a controlled substance with no medical use, in the same category as heroin and LSD.

Despite increasing acceptance, there is little rigorous research on the benefits and harms of marijuana. Last year a government-commissioned group concluded that the lack of scientific information about marijuana and CBD poses a risk to public health.

Before sales of Epidiolex can begin, the Drug Enforcement Administration must formally reclassify CBD into a different category of drugs that have federal medical approval.

GW Pharmaceuticals makes the drug in the U.K. from cannabis plants that are specially bred to contain high levels of CBD. And the company plans to continue importing the medicine, bypassing onerous U.S. regulations on manufacturing restricted substances.

___

The Associated Press Health & Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Terre Haute
Broken Clouds
67° wxIcon
Hi: 85° Lo: 65°
Feels Like: 67°
Robinson
Clear
67° wxIcon
Hi: 84° Lo: 66°
Feels Like: 67°
Indianapolis
Broken Clouds
68° wxIcon
Hi: 84° Lo: 65°
Feels Like: 68°
Rockville
Clear
59° wxIcon
Hi: 84° Lo: 64°
Feels Like: 59°
Casey
Clear
67° wxIcon
Hi: 84° Lo: 65°
Feels Like: 67°
Brazil
Broken Clouds
67° wxIcon
Hi: 84° Lo: 66°
Feels Like: 67°
Marshall
Broken Clouds
67° wxIcon
Hi: 84° Lo: 64°
Feels Like: 67°
Partly cloudy and calm
WTHI Planner
WTHI Temps
WTHI Radar

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Confirmed Cases: 198248

Reported Deaths: 7866
CountyConfirmedDeaths
Cook1124844933
Lake12852447
DuPage12427522
Kane9878305
Will9413346
St. Clair4107161
Winnebago3797131
McHenry3250114
Madison270276
Kankakee180269
Rock Island176436
Champaign169319
Peoria166736
Kendall139823
Unassigned1347209
Sangamon129733
DeKalb94730
LaSalle80124
Boone76923
Jackson73120
McLean67015
Macon65023
Tazewell6108
Adams5576
Coles49221
Randolph4747
Williamson4346
Ogle4165
Clinton41517
Whiteside36617
Grundy3345
Stephenson3346
Union32723
Monroe32313
Knox3131
Jefferson29219
Morgan2696
Iroquois26711
Henry2531
Vermilion2342
Cass23311
Bureau2313
Franklin1941
Warren1910
Perry1842
Macoupin1823
Lee1781
Montgomery1717
Marion1650
Effingham1631
Woodford1583
Logan1571
McDonough14515
Christian1434
Saline1342
Jo Daviess1301
Livingston1223
Douglas1222
Jersey1172
Pulaski941
Clark872
Shelby861
Mercer764
Moultrie750
White710
Johnson710
Fayette693
Washington670
Wayne662
Piatt630
Hancock631
Bond623
Carroll614
Jasper607
Greene590
Cumberland573
Menard570
Mason560
Lawrence510
Gallatin512
Ford502
Massac410
Wabash400
Alexander370
Fulton350
De Witt340
Crawford300
Edgar290
Hamilton290
Marshall280
Clay260
Pike240
Scott210
Edwards200
Richland200
Hardin180
Schuyler180
Brown150
Putnam140
Henderson130
Pope110
Calhoun90
Stark70
Out of IL10

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Confirmed Cases: 75862

Reported Deaths: 3069
CountyConfirmedDeaths
Marion16088730
Lake7688278
Elkhart492685
Allen4002163
St. Joseph357883
Hamilton2829104
Vanderburgh202213
Hendricks1927108
Cass18029
Johnson1789119
Porter135539
Clark128749
Tippecanoe123811
Madison100665
LaPorte93130
Howard91365
Kosciusko86812
Bartholomew81747
Floyd80948
Marshall79323
Monroe76631
Delaware74552
Dubois70812
Vigo69911
Noble68829
Boone68746
Hancock68339
Jackson5965
Warrick58830
Shelby56527
LaGrange56310
Grant52930
Dearborn51228
Morgan49334
Clinton4444
Henry40620
Wayne38510
White37611
Montgomery35921
Lawrence35227
Harrison34823
Decatur34132
Putnam3128
Daviess27720
Miami2772
Scott27210
Jasper2552
Greene25434
Franklin24615
DeKalb2384
Gibson2314
Jennings22712
Steuben2133
Ripley2138
Carroll1962
Fayette1947
Perry18713
Posey1790
Starke1787
Wells1742
Orange17424
Fulton1722
Wabash1703
Jefferson1672
Knox1610
Whitley1556
Tipton14312
Washington1421
Sullivan1381
Spencer1373
Clay1245
Huntington1243
Randolph1244
Newton12010
Adams1092
Owen991
Jay920
Rush854
Pulaski811
Fountain742
Brown741
Blackford652
Ohio656
Benton640
Pike590
Vermillion580
Switzerland530
Parke511
Martin480
Crawford450
Union410
Warren241
Unassigned0206